Recent progress in research on ribosome inactivating proteins

Current Protein and Peptide Science

Volumn 11, Issue 1, 2010, Pages 37-53

  Ng, T B ^a   Wong, Jack Ho ^a   Wang, Hexiang ^b  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA MOMORCHARIN; BENINCASIN; BETA KIRILOWIN; BETA MOMORCHARIN; BETA TRICHOSANTHIN; CALCAELIN; CHARANTIN; CHARYBDIN; COCHININ B; DIZOCILPINE; HERBACEOUS AGENT; IMMUNOTOXIN; KIRILOWIN; LUFFACULIN; LUFFACYLIN; LUFFANGULIN; LUFFIN; MOMORDIN; MOMORGROSVIN; MOSCHIN; NEOTRICHOCANTIN; NEUROTOXIN; PISAVIN; RIBOSOME INACTIVATING PROTEIN; RIBOSOME INACTIVATING PROTEIN 1; SAPORIN; TEXANIN; TRICHOKIRIN S; TRICHOSANTHIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VEGETABLE PROTEIN;

ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CELL FREE SYSTEM; CHOLINERGIC NERVE CELL; CLINICAL RESEARCH; CONJUGATION; CRYSTAL STRUCTURE; CUCUMBER; CYTOTOXICITY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; MEDICINAL PLANT; MOLECULAR WEIGHT; MUSHROOM; NEUROSCIENCE; NEUROTOXICITY; NONHUMAN; PLANT; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RIBOSOME; RNA TRANSLATION; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

ANIMALS; HUMANS; IMMUNOTOXINS; NEURONS; PROTEIN CONFORMATION; RIBOSOME INACTIVATING PROTEINS; RIBOSOME INACTIVATING PROTEINS, TYPE 1; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77950166344     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920310790274662     Document Type: Review

References (190)

1. Shaw, P.C.; Lee, K.M.; Wong, K.B. Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties. Toxicon. 2005, 45(6), 683-689.
2. Lin, P.; Xia, L.; Wong, J.H.; Ng, T.B.; Ye, X.; Wang, S.; Shi, X. Lipid transfer proteins from Brassica campestris and mung bean surpass mung bean chitinase in exploitability. J. Pept. Sci., 2007, 13(10), 642-648.
3. Broekaert, W.F.; Mariën, W.; Terras, F.R.; De Bolle, M.F.; Proost, P.;Van Damme, J.; Dillen, L.; Claeys, M.; Rees, S.B.; Vanderleyden, J.; Cammue, B.P.A. Antimicrobial peptides from Amaranthus caudatus seeds with sequence homology to the cysteine/glycinerich domain of chitin-binding proteins. Biochemistry, 1992, 31(17), 4308-4314.
4. Ho, V.S.; Ng, T.B. A Bowman-Birk trypsin inhibitor with antiproliferative activity from Hokkaido large black soybeans. J. Pept. Sci., 2008, 14(3), 278-282.
5. Pelegrini, P.B.; Lay, F.T.; Murad, A.M.; Anderson, M.A.; Franco, O.L. Novel insights on the mechanism of action of alpha-amylase inhibitors from the plant defensin family. Proteins, 2008, 73(3), 719-729.
6. Oliveira, M.D.; Andrade, C.A.; Santos-Magalhães, N.S.; Coelho, L.C.; Teixeira, J.A.; Carneiro-da-Cunha, M.G.; Correia, M.T. Purification of a lectin from Eugenia uniflora L. seeds and its potential antibacterial activity. Lett. Appl. Microbiol., 2008, 46(3), 371-376.
7. Pusztai, A.; Bardocz, S.; Ewen, S.W. Uses of plant lectins in bio-science and biomedicine. Front Biosci., 2008, 13, 1130-1140.
8. Boleti, A.P.; Freire, M.G.; Coelho, M.B.; Silva, W.; Baldasso, P.A.; Gomes, V.M.; Marangoni, S.; Novello, J.C.; Macedo, M.L. Insecticidal and antifungal activity of a protein from Pouteria torta seeds with lectin-like properties. J. Agric. Food Chem., 2007, 55(7), 2653-2658.
9. van der Meer, F.J.; de Haan, C.A.; Schuurman, N.M.; Haijema, B.J.; Peumans, W.J.; Van Damme, E.J.; Delputte, P.L.; Balzarini, J.; Egberink, H.F. Antiviral activity of carbohydrate-binding agents against Nidovirales in cell culture. Antiviral Res., 2007, 76(1), 21-29.
10. Wang, B.; Shi, X.; Guo, C.; Ye, X.; Wang, Z.; Rao, P. Isolation and purification of ribosome-inactivating proteins from bitter melon seeds by ion exchange chromatographic columns in series] Se Pu, 2004, 22(5), 543-546.
11. Ferens, WA.; Hovde, C.J. The non-toxic A subunit of Shiga toxin type 1 prevents replication of bovine immunodeficiency virus in infected cells. Virus Res., 2007, 125(1), 29-41.
12. Leung, S.O.; Yeung, H.W.; Leung, K.N. The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia). Immunopharmacology, 1987, 13(3), 159-171.
13. Stirpe, F.; Battelli, M.G. Ribosome-inactivating proteins: progress and problems. Cell Mol. Life Sci., 2006, 63(16), 1850-1866. Review.
14. Park, S.W., Prithiviraj, B.; Vepachedu, R.; Vivanco, J.M. Isolation and purification of ribosome-inactivating proteins. Methods Mol. Biol., 2006, 318, 335-347.
15. Girbés T, Ferreras JM, Arias FJ, Stirpe F. Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants, fungi and bacteria. Mini Rev. Med. Chem., 2004, 4(5), 461-476.
16. Robertus, J.D.; Monzingo, A.F. The structure of ribosome inactivating proteins. Mini Rev. Med. Chem., 2004, 4, 477-486.
17. Battelli, M.G. Cytotoxicity and toxicity to animals and humans of ribosome-inactivating proteins. Mini Rev. Med. Chem., 2004, 4(5), 513-521.
18. Roberts, L.M.; Lord, J.M.; Ribosome-inactivating, proteins: entry into mammalian cells and intracellular routing. Mini Rev. Med. Chem., 2004, 4, 505-512.
19. Guo, Q.; Zhou, W.; Too, H.M.; Li, J.; Liu, Y.; Bartlam, M.; Dong, Y.; Wong, K.B.; Shaw, P.C.; Rao, Z.; Substrate binding and catalysis in trichosanthin occur in different sites as revealed by the complex structures of several E85 mutants. Protein Eng., 2003, 16(6), 391-396.
20. Wong, R.N.; Dong, T.X.; Ng, T.B.; Choi, W.T.; Yeung, H.W. alpha-Kirilowin, a novel ribosome-inactivating protein from seeds of Trichosanthes kirilowii (family Cucurbitaceae): a comparison with beta-kirilowin and other related proteins. Int. J. Pept. Protein Res., 1996, 47(1-2), 103-109.
21. Dong, T.X.; Ng, T.B.; Yeung, H.W., Wong, R.N. Isolation and characterization of a novel ribosome-inactivating protein, betakirilowin, from the seeds of Trichosanthes kirilowii. Biochem. Biophys. Res. Commun., 1994, 199(1), 387-393.
22. Li, H.G.; Xu, S.Z.; Wu, S.; Yan, L.; Li, J.H.; Wong, R.N.; Shi, Q.L.; Dong, Y.C. Role of Arg163 in the N-glycosidase activity of neo-trichosanthin. Protein Eng., 1999, 12(11), 999-1004.
23. Yeung, H.W.; Li, W.W. Beta-trichosanthin: a new abortifacient protein from the Chinese drug, wangua, Trichosanthes cucumeroides. Int. J. Pept. Protein Res., 1987, 29(3), 289-292.
24. Tsang, K.Y.; Ng, T.B. Isolation and characterization of a new ribosome inactivating protein, momorgrosvin, from seeds of the monk's fruit Momordica grosvenorii. Life Sci., 2001, 68(7), 773-784.
25. Ng, T.B.; Wong, R.N.; Yeung, H.W. Two proteins with ribosome- inactivating, cytotoxic and abortifacient activities from seeds of Luffa cylindrica roem (Cucurbitaceae). Biochem. Int., 1992, 27(2), 197-207.
26. Wang, H.X.; Ng, T.B. Purification of allivin, a novel antifungal protein from bulbs of the round-cloved garlic. Life Sci., 2001, 70(3), 357-365.
27. Touloupakis, E.;Gessmann, R.; Kavelaki, K.; Christofakis, E.; Petratos, K.; Ghanotakis, D.F. Isolation, characterization, sequencing and crystal structure of charybdin, a type 1 ribosome-inactivating protein from Charybdis maritima agg. FEBS J., 2006, 273(12), 2684-2692.
28. Chambery, A.; de Donatom, A.; Bolognesi, A.; Polito, L.; Stirpe, F.; Parente A. Sequence determination of lychnin, a type 1 ribosome-inactivating protein from Lychnis chalcedonica seeds. Biol. Chem., 2006, 387(9), 1261-1266.
29. Roy, S.; Sadhana, P.; Begum, M.; Kumar, S.; Lodha, M.L.; Kapoor, H.C. Purification, characterization and cloning of antiviral/ ribosome inactivating protein from Amaranthus tricolor leaves. Phytochemistry, 2006, 67(17), 1865-1873.
30. Di Maro, A.; Chambery, A.; Daniele, A.; Casoria, P.; Parente, A. Isolation and characterization of heterotepalins, type 1 ribosome. Phytochemistry, 2007, 68,767-776.
31. Chambery, A.; Pisante, M.; Di Maro, A.; Di Zazzo, E.; Ruvo, M.; Costantini, S.; Colonna, G.; Parente, A. Invariant Ser211 is involved in the catalysis of PD-L4, type I RIP from Phytolacca dioica leaves. Proteins, 2007, 67(1), 209-218.
32. Barbieri, L.; Polito, L.; Bolognesi, A.; Ciani, M.; Pelosi, E.; Farini, V.; Jha, A.K.; Sharma, N.; Vivanco, J.M.; Chambery, A.; Parente, A.; Stirpe, F. Ribosome-inactivating proteins in edible plants and purification and characterization of a new ribosome-inactivating protein from Cucurbita moschata. Biochim. Biophys. Acta, 2006, 1760(5), 783-792.
33. Chuethong, J.; Oda, K.; Sakurai, H.; Saiki, I.; Leelamanit, W.; Cochinin, B. a novel ribosome-inactivating protein from the seeds of Momordica cochinchinensis. Biol. Pharm. Bull., 2007, 30(3), 428-432.
34. Zhang, D.; Halaweish, F.T. Isolation and characterization of ribosome-inactivating proteins from Cucurbitaceae. Chem. Biodivers., 2007, 4(3), 431-442.
35. Xu, L.; Wang, Y.; Wang, L.; Gao, Y.; An, C. TYchi, a novel chitinase with RNA N-glycosidase and anti-tumor activities. Front Biosci., 2008, 13, 3127-3135.
36. Citores, L.; Rojo, M.A.; Jiménez, P.; Ferreras, J.M.; Iglesias, R.; Aranguez, I.; Girbés, T. Transient occurrence of an ebulin-related D-galactose-lectin in shoots of Sambucus ebulus L. Phytochemistry, 2008, 69(4), 857-864.
37. De-la-Peña, C.; Badri, D.V.; Vivanco, J.M. Novel role for pectin methylesterase in Arabidopsis: a new function showing ribosome-inactivating protein (RIP) activity. Biochim. Biophys. Acta, 2008, 1780(5), 773-783.
38. Choudhary, N.; Kapoor, H.C.; Lodha, M.L. Cloning and expression of antiviral/ribosome-inactivating protein from Bougainvillea x buttiana. J. Biosci., 2008, 33(1), 91-101.
39. Gao, W.; Ling, J.; Zhong, X.; Liu, W.; Zhang, R.; Yang, H.; Cao, H.; Zhang, Z. Luffin-S-a small novel ribosome-inactivating protein from Luffa cylindrica. Characterization and mechanism studies. FEBS Lett., 1994, 347(2-3), 257-260.
40. Pu, Z.; Lu, B.Y.; Liu, W.Y.; Jin, S.W. Characterization of the enzymatic mechanism of gamma-momorcharin, a novel ribosome-inactivating protein with lower molecular weight of 11,500 purified from the seeds of bitter gourd (Momordica charantia). Biochem. Biophys. Res. Commun., 1996, 229(1), 287-294.
41. Wang, H.; Ng, T.B. Luffangulin, a novel ribosome inactivating peptide from ridge gourd (Luffa acutangula) seeds. Life Sci., 2002, 70(8), 899-906.
42. Parkash, A.; Ng, T.B.; Tso, W.W. Isolation and characterization of luffacylin, a ribosome inactivating peptide with anti-fungal activity from sponge gourd (Luffa cylindrica) seeds. Peptides, 2002, 23(6), 1019-1024.
43. Parkash, A.; Ng, T.B.; Tso, W.W. Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica charantia) seeds. J. Pept. Res., 2002, 59(5), 197-202.
44. Ng, T.B.; Parkash, A.; Tso, W.W. Purification and characterization of moschins, arginine-glutamate-rich proteins with translation inhibiting activity from brown pumpkin (Cucurbita moschata) seeds. Protein Expr. Purif., 2002, 26(1), 9-13.
45. Ng, T.B.; Parkash, A.; Tso, W.W. Purification and characterization of alpha- and beta-benincasins, arginine/glutamate-rich peptides with translation-inhibiting activity from wax gourd seeds. Peptides, 2003, 24(1), 11-6.
46. Li, F.; Yang, X.X.; Hu, W.G.; Xia, H.C.; Li, Z.; Zhang, Z.C. Purification and characterization of trichokirin-S1, a novel ribosomeinactivating peptide from seeds of Trichosanthes kirilowii Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003, 35(9), 841-846.
47. Wang, H.X.; Ng, T.B. Lagenin, a novel ribosome-inactivating protein with ribonucleolytic activity from bottle gourd (Lagenaria siceraria) seeds. Life Sci., 2000, 67(21), 2631-2638.
48. Ng, T.B.; Parkash, A. Hispin, a novel ribosome inactivating protein with antifungal activity from hairy melon seeds. Protein Expr. Purif., 2002, 26(2), 211-217.
49. Lam, S.S.; Wang, H.; Ng, T.B. Purification and characterization of novel ribosome inactivating proteins, alpha- and beta-pisavins, from seeds of the garden pea Pisum sativum. Biochem. Biophys. Res. Commun., 1998, 253(1), 135-142.
50. Ng, T.B.; Lam, Y.W.; Wang, H. Calcaelin, a new protein with translation-inhibiting, antiproliferative and antimitogenic activities from the mosaic puffball mushroom Calvatia caelata. Planta Med., 2003, 69(3), 212-217.
51. Wang, H.X.; Ng, T.B. Flammulin: a novel ribosome-inactivating protein from fruiting bodies of the winter mushroom Flammulina velutipes. Biochem. Cell Biol., 2000, 78(6), 699-702.
52. Wang, H.; Ng, T.B. Isolation and characterization of velutin, a novel low-molecular-weight ribosome-inactivating protein from winter mushroom (Flammulina velutipes) fruiting bodies. Life Sci., 2001, 68(18), 2151-2158.
53. Lam, S.K.; Ng, T.B. Hypsin, a novel thermostable ribosome-inactivating protein with antifungal and antiproliferative activities from fruiting bodies of the edible mushroom Hypsizigus marmoreus. Biochem. Biophys. Res. Commun., 2001, 285(4), 1071-1075.
54. Lam, S.K.; Ng, T.B. First simultaneous isolation of a ribosome inactivating protein and an antifungal protein from a mushroom (Lyophyllum shimeji) together with evidence for synergism of their antifungal effects. Arch. Biochem. Biophys., 2001, 393(2), 271-280.
55. Wong, J.H.; Wang, H.X.; Ng, T.B. Marmorin, a new ribosome inactivating protein with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from the mushroom Hypsizigus marmoreus. Appl. Mircrobiol. Biotechnol., 2008, 81(4), 669-674.
56. Wang, H.X.; Ng, T.B. Isolation of pleuturegin, a novel ribosome-inactivating protein from fresh sclerotia of the edible mushroom Pleurotus tuber-regium. Biochem. Biophys. Res. Commun., 2001, 288(3), 718-721.
57. Yao, Q.Z.; Yu, M.M.; Ooi, L.S.; Ng, T.B.; Chang, S.T.; Sun, S.S.; Ooi, V.E. Isolation and Characterization of a type 1 ribosome-inactivating protein from fruiting bodies of the edible mushroom (Volvariella volvacea). J. Agric. Food Chem., 1998, 46(2), 788-792.
58. Lin, A.; Lee, T.M.; Rern, J.C. Tricholin, a new antifungal agent from Trichoderma viride, and its action in biological control of Rhizoctonia solani. J. Antibiot. (Tokyo), 1994, 47(7), 799-805.
59. Parente, D.; Raucci, G.; Celano, B.; Pacilli, A.; Zanoni, L.; Canevari, S.; Adobati, E.; Colnaghi, M.I.; Dosio, F.; Arpicco, S.; Cattel, L.; Mele, A.; De Santis, R. Clavin. a type-1 ribosome-inactivating protein from Aspergillus clavatus IFO 8605. cDNA isolation, heterologous expression, biochemical and biological characterization of the recombinant protein. Eur. J. Biochem., 1996, 239(2), 272-280.
60. Salvarelli, S.; Muñoz, S.; Conde, F.P. Purification and characterization of a ribonuclease from Aspergillus giganteus IFO 5818, the gigantin. Immunological and enzymic comparison with alphasarcin. Eur. J. Biochem., 1994, 225(1), 243-251.
61. Hauf, N.; Caraborty, T. Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J. Immunol., 2003, 170, 2074-2082.
62. Hou, X.; Chen, M.; Chen, L.; Meehan, E.J.; Xie, J.; Huang, M. X-ray sequence and crystal structure of luffaculin 1, a novel type 1 ribosome-inactivating protein. BMC Struct. Biol., 2007, 7, 29.
63. Ma, Q.; Yao, G.; Wu, S.; Li, H.; Li, J.; Dong, Y. Crystallization and preliminary X-ray analysis of luffaculin, a ribosome-inactivating protein from sponge-gourd seeds. Acta Crystallogr. D Biol. Crystallogr., 2000, 56(Pt 2), 185-186.
64. Ruggieroa, A.; Chambery, A.; Di Maro, A.; Mastroianni, A.; Parente, A.; Berisio, R. Crystallization and preliminary X-ray diffraction analysis of PD-L1, a highly glycosylated ribosome inactivating protein with DNase activity. Protein Pept. Lett., 2007, 14(4), 407-409.
65. Ruggiero, A.; Chambery, A.; Di, Maro. A.; Pisante, M.; Parente, A.; Berisio, R. Crystallization and preliminary X-ray diffraction analysis of PD-L4, a ribosome inactivating protein from Phytolacca dioica L. leaves. Protein Pept. Lett., 2007, 14(1), 97-100.
66. Mansouri, S.; Nourollahzadeh, E.; Hudak, K.A. Pokeweed antiviral protein depurinates the sarcin/ricin loop of the rRNA prior to binding of aminoacyl-tRNA to the ribosomal A-site. RNA, 2006, 12(9), 1683-1692.
67. Roday, S.; Saen-oon, S.; Schramm, V.L. Vinyldeoxyadenosine in a sarcin-ricin RNA loop and its binding to ricin toxin a-chain. Biochemistry, 2007, 46(21), 6169-6182.
68. Wang, M.; Hudak, K.A. A novel interaction of pokeweed antiviral protein with translation initiation factors 4G and iso4G: a potential indirect mechanism to access viral RNAs. Nucleic Acids Res., 2006, 4, 174-181.
69. Baykal, U.; Tumer, N.E. The C-terminus of pokeweed antiviral protein has distinct roles in transport to the cytosol, ribosome depurination and cytotoxicity. Plant J., 2007, 49(6), 995-1007.
70. Nagasawa, Y.; Fujii,K.; Yoshikawa, T.; Kobayashi, Y.; Kondo, T. Pokeweed antiviral protein region Gly209-Lys225 is critical for RNA N-glycosidase activity of the prokaryotic ribosome. Phytochemistry, 2008, 69(8), 1653-1660.
71. Ayub, M.J.; Smulski, C.R.; Ma, K.W.; Levin, M.J.; Shaw, P.C.; Wong, K.B. The C-terminal end of P proteins mediates ribosome inactivation by trichosanthin but does not affect the pokeweed antiviral protein activity. Biochem. Biophys. Res. Commun., 2008, 369(2), 314-319
72. Chan, D.S.; Chu, L.O.; Lee, K.M.; Too, P.H.; Ma, K.W.; Sze, K.H.; Zhu, G.; Shaw, P.C.; Wong, K.B. Interaction between trichosanthin, a ribosome-inactivating protein, and the ribosomal stalk protein P2 by chemical shift perturbation and mutagenesis analyses. Nucleic Acids Res., 2007, 35(5), 1660-1672.
73. Ferens, W.A.; Haruna, J.; Cobbold, R.; Hovde, C.J. Low numbers of intestinal Shiga toxin-producing E. coli correlate with a poor prognosis in sheep infected with bovine leukemia virus. J. Vet. Sci., 2008, 9(4), 375-379.
74. Korennykh, A.V.; Correll, C.C.; Piccirilli, J.A. Evidence for the importance of electrostatics in the function of two distinct families of ribosome inactivating toxins. RNA, 2007, 13(9), 1391-1396.
75. Günhan, E.; Swe, M.; Palazoglu, M.; Voss, J.C.; Chalupa, L.M. Expression and purification of cysteine introduced recombinant saporin. Protein Expr. Purif. 2008, 58(2), 203-209.
76. Sawasaki, T.; Nishihara, M.; Endo, Y. RIP and RALyase cleave the sarcin/ricin domain, a critical domain for ribosome function, during senescence of wheat coleoptiles. Biochem. Biophys. Res. Commun., 2008, 370(4), 561-565.
77. Xu, J.; Wang, H.; Fan, J. Expression of a ribosome-inactivating protein gene in bitter melon is induced by Sphaerotheca fuliginea and abiotic stimuli. Biotechnol. Lett., 2007, 29(10), 1605-1610.
78. Ruan, X.L.; Liu, L.F.; Li, H.P.; Transgenic tobacco plants with ribosome inactivating protein gene cassin from Cassia occidentalis and their resistance to tobacco mosaic virus. Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao. 2007, 33(6), 517-523.
79. Choudhary, N.L.; Yadav, O.P.; Lodha, M.L. Ribonuclease, deoxy-ribonuclease, and antiviral activity of Escherichia coli-expressed Bougainvillea xbuttiana antiviral protein. Biochemistry (Mosc), 2008, 73(3), 273-277.
80. Huang, H.; Chan, H.; Wang, Y.Y.; Ouyang, D.Y.; Zheng, Y.T.; Tam, S.C. Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells. Life Sci., 2006, 79(13), 1287-1292.
81. Chen, G.F.; Huang, W.G.; Chen, F.Y.; Shan, J.L.; Protective effects of trichosanthin in Herpes simplex virus-1 encephalitis in mice. Zhongguo Dang Dai Er Ke Za Zhi, 2006, 8(3), 239-241.
82. Ouyang, D.Y.; Chan, H.; Wang, Y.Y.; Huang, H.; Tam, S.C.; Zheng, Y.T. An inhibitor of c-Jun N-terminal kinases (CEP-11004) counteracts the anti-HIV-1 action of trichosanthin. Biochem. Biophys. Res. Commun., 2006, 339(1), 25-29.
83. Zhang, X.Y.; Wu, Y.; Yan, J.Y.; Gao, Y.; Wang, Y.; Mi, S.L.; An, C.C. Y55 and D78 are crucial amino acid residues of a new IgE epitope on trichosanthin. Biochem. Biophys. Res. Commun., 2006, 343(4), 1251-1256.
84. An, Q.; Lei, Y.; Jia, N.; Zhang, X.; Bai, Y.; Yi, J.; Chen, R.; Xia, A.; Yang, J.; Wei, S.; Cheng, X.; Fan, A.; Mu, S.; Xu, Z. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics. Biomol. Eng., 2007, 24, 643-649.
85. An, Q.; Wei, S.; Mu, S.; Zhang, X.; Lei, Y.; Zhang, W.; Jia, N.; Cheng, X.; Fan, A.; Li, Z.; Xu, Z. Mapping the antigenic determinants and reducing the immunogenicity of trichosanthin by site-directed mutagenesis. J. Biomed. Sci., 2006, 13(5), 637-643.
86. Xia, X.F.; Zhang, F.; Shaw, P.C.; Sui, S.F. Trichosanthin induces leakage and membrane fusion of liposome. IUBMB Life, 2003, 55, 681-687.
87. Gerashchenko, D.; Blanco-Centurion, C.A.; Miller, J.D.; Shiromani, P.J. Insomnia following hypocretin2-saporin lesions of the substantia nigra. Neuroscience, 2006, 137(1), 29-36.
88. Blanco-Centurion, C.A.; Shiromani, A.; Winston, E.; Shiromani, P.J. Effects of hypocretin-1 in 192-IgG-saporin-lesioned rats. Eur. J. Neurosci., 2006, 24(7), 2084-2088.
89. Kaur, S.; Junek, A.; Black, M.A.; Semba, K. Effects of ibotenate and 192IgG-saporin lesions of the nucleus basalis magnocellularis/ substantia innominata on spontaneous sleep and wake states and on recovery sleep after sleep deprivation in rats. J. Neurosci., 2008, 28(2), 491-504.
90. Nolan, B.C.; Freeman, J.H. Purkinje cell loss by OX7-saporin impairs acquisition and extinction of eyeblink conditioning. Learn Mem., 2006, 13(3), 359-365.
91. Berdiev, R.K.; Chepurnov, S.A.; Veening, J.G.; Chepurnova, N.E.; van Luijtelaar, G. The role of the nucleus basalis of Meynert and reticular thalamic nucleus in pathogenesis of genetically determined absence epilepsy in rats: a lesion study. Brain Res., 2007, 1185, 266-274.
92. Traissard, N.; Herbeaux, K.; Cosquer, B.; Jeltsch, H.; Ferry, B.; Galani, R.; Pernon, A.; Majchrzak, M.; Cassel, J.C. Combined damage to entorhinal cortex and cholinergic basal forebrain neurons, two early neurodegenerative features accompanying Alzheimer's disease: effects on locomotor activity and memory functions in rats. Neuropsychopharmacology, 2007, 32(4), 851-871.
93. Scattoni, M.L.; Adriani, W.; Calamandrei, G.; Laviola, G.; Ricceri, L. Long-term effects of neonatal basal forebrain cholinergic lesions on radial maze learning and impulsivity in rats. Behav. Pharmacol., 2006, 17(5-6), 517-524.
94. Willis, C.L.; Ray, D.E.; Marshall, H.; Elliot, G.; Evans, J.G.; Kind, C.N. Basal forebrain cholinergic lesions reduce heat shock protein 72 response but not pathology induced by the NMDA antagonist MK-801 in the rat cingulate cortex. Neurosci. Lett., 2006, 407(2), 112-117.
95. Cabrera, S.M., Chavez, C.M.; Corley, S.R.; Kitto, M.R.; Butt, A.E. Selective lesions of the nucleus basalis magnocellularis impair cognitive flexibility. Behav. Neurosci., 2006; 120(2), 298-306.
96. Knox, D.; Berntson, G.G. Effect of nucleus basalis magnocellularis cholinergic lesions on fear-like and anxiety-like behavior. Behav. Neurosci., 2006, 120(2), 307-312.
97. Fitz, N.F.; Gibbs, R.B.; Johnson, D.A. Aversive stimulus attenuates impairment of acquisition in a delayed match to position T-maze task caused by a selective lesion of septo-hippocampal cholinergic projections. Brain Res. Bull., 2006, 69(6), 660-665.
98. Marcos, B.; Gil-Bea, F.J.; Hirst, W.D.; García-Alloza, M.; Ramírez, M.J. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release. Eur. J. Neurosci., 2006, 24(5), 1299-1306.
99. van der Staay, F.J.; Bouger, P.; Lehmann, O.; Lazarus, C.; Cosquer, B.; Koenig, J.; Stump, V.; Cassel, J.C. Long-term effects of immunotoxic cholinergic lesions in the septum on acquisition of the cone-field task and noncognitive measures in rats. Hippocampus, 2006, 16(12), 1061-1079.
100. Garcia-Alloza, M.; Zaldua, N.; Diez-Ariza, M.; Marcos, B.; Lasheras, B.; Javier, Gil-Bea F.; Ramirez, M.J. Effect of selective cholinergic denervation on the serotonergic system: implications for learning and memory. J. Neuropathol. Exp. Neurol., 2006, 65(11), 1074-1081.
101. Severino, M.; Pedersen, A.F.; Trajkovska, V.; Christensen, E.; Lohals, R.; Veng, L.M.; Knudsen, G.M.; Aznar, S. Selective immunolesion of cholinergic neurons leads to long-term changes in 5-HT2A receptor levels in hippocampus and frontal cortex. Neurosci. Lett., 2007, 428(1), 47-51.
102. Hawkes, C.; Kabogo, D.; Amritraj, A.; Kar, S. Up-regulation of cation-independent mannose 6-phosphate receptor and endosomal-lysosomal markers in surviving neurons after 192-IgG-saporin administrations into the adult rat brain. Am. J. Pathol., 2006, 169(4), 1140-1154.
103. Gibbs, R.B.; Johnson, D.A.; Cholinergic lesions produce task-selective effects on delayed matching to position and configural association learning related to response pattern and strategy. Neurobiol. Learn Mem., 2007, 88(1), 19-32.
104. Tait, D.S.; Brown, V.J. Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats. Behav. Brain Res., 2008, 87,100-108.
105. Fletcher, B.R.; Baxter, M.G.; Guzowski, J.F.; Shapiro, M.L.; Rapp, P.R. Selective cholinergic depletion of the hippocampus spares both behaviorally induced Arc transcription and spatial learning and memory. Hippocampus, 2007, 17(3), 227-234.
106. Bailey, A.M.; Lee, J.M. Lesions to the nucleus basalis magnocellularis lower performance but do not block the retention of a previously acquired learning set. Brain Res., 2007, 1136(1), 110-121.
107. Allen, J.W.; Mantyh, P.W.; Horais, K.; Tozier, N.; Rogers, S.D.; Ghilardi, J.R.; Cizkova, D.; Grafe, M.R.; Richter, P.; Lappi, D.A.; Yaksh, T.L. Safety evaluation of intrathecal substance P-saporin, a targeted neurotoxin, in dogs. Toxicol. Sci., 2006, 91, 286-298.
108. Castro, A.R.; Pinto, M.; Lima, D.; Tavares, I. Secondary hyperalgesia in the monoarthritic rat is mediated by GABAB and NK1 receptors of spinal dorsal horn neurons: a behavior and c-fos study. Neuroscience, 2006, 141(4), 2087-2095.
109. Vera-Portocarrero, L.P.; Zhang, E.T.; King, T.; Ossipov, M.H.; Vanderah, T.W.; Lai, J.; Porreca, F. Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways. Pain, 2007, 129(1-2), 35-45.
110. Abdala, A.P.; Schoorlemmer, G.H.; Colombari, E. Ablation of NK1 receptor bearing neurons in the nucleus of the solitary tract blunts cardiovascular reflexes in awake rats. Brain Res., 2006, 1119, 165-173.
111. Ohtori, S.; Inoue, G.; Koshi, T.; Ito, T.; Doya, H.; Moriya, H.; Takahashi, K. Substance P-saporin down-regulates substance P receptor immunoreactive sensory dorsal root ganglion neurons innervating the lumbar intervertebral discs in rats. Spine. 2006, 31(26), 2987-2991.
112. Wiley, R.G. Substance P receptor-expressing dorsal horn neurons: lessons from the targeted cytotoxin, substance P-saporin. Pain, 2008, 136, 7-10.
113. Truitt, W.A.; Sajdyk, T.J.; Dietrich, A.D.; Oberlin, B.; McDougle, C.J.; Shekhar, A. From anxiety to autism: spectrum of abnormal social behaviors modeled by progressive disruption of inhibitory neuronal function in the basolateral amygdala in Wistar rats. Psychopharmacology (Berl), 2007, 191(1), 07-18.
114. Potts, J.T.; Fong, A.Y.; Anguelov, P.I.; Lee, S.; McGovern, D.; Grias, I. Targeted deletion of neurokinin-1 receptor expressing nucleus tractus solitarii neurons precludes somatosensory depression of arterial baroreceptor-heart rate reflex. Neuroscience, 2007, 145(3), 1168-1181.
115. Wiley, R.G.; Kline, R.H.; 4th, Vierck, C.J.; Jr. Anti-nociceptive effects of selectively destroying substance P receptor-expressing dorsal horn neurons using [Sar9,Met(O2)11]-substance P-saporin: behavioral and anatomical analyses. Neuroscience, 2007, 146(3), 1333-1345.
116. Shen, F.M.; Wang, J.; Ni, C.R.; Yu, J.G.; Wang, W.Z.; Su, D.F. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors. Clin. Exp. Pharmacol. Physiol., 2007, 34(8), 702-707.
117. Vera-Portocarero, L.P.; Xie, J.Y.; Kowal, J.; Ossipor, M.H.; King, T.; Porreca, F. Descending facilitation from the rostral ventromedical medulla maintains visceral pain in rats with experimental panccreatitis. Gastroenterology, 2006, 130, 2155-2164.
118. Shank, E.J.; Seitz, P.K.; Bubar, M.J.; Stutz, S.J.; Cunningham, K.A. Selective ablation of GABA neurons in the ventral tegmental area increases spontaneous locomotor activity. Behav. Neurosci., 2007, 121(6), 1224-1233.
119. Pedrino, G.R.; Maurino, I.; de Almeida, Colombari, D.S.; Cravo, S.L.; Role of catecholaminergic neurones of the caudal ventrolateral medulla in cardiovascular responses induced by acute changes in circulating volume in rats. Exp. Physiol., 2006, 91 (6), 995-1005.
120. Milstein, J.A.; Lehmann, O.; Theobald, D.E.; Dalley, J.W.; Robbins, T.W. Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat. Psychopharmacology (Berl), 2007, 190(1), 51-63.
121. Pijpers, H.; Winkelman, B.R.; Bronsing, R.; Ruigrok, T.J. Selective impairment of the cerebellar C1 module involved in rat hindlimb control reduces step-dependent modulation of cutaneous reflexes. J. Neurosci., 2008, 28, 2179-2189.
122. Sha, O.; Kwong, W.H.; Pang Cho, E.Y.; Wai Yew, D.T; Ng, T.B. Different neuronal toxicity of single-chain ribosome-inactivating proteins on the rat retina. Toxicon, 2008, 51(1), 45-53.
123. Melzig, M.F.; Hebestreit, P.; Gaidi, G.; Lacaille-Dubois, M.A. Structure-activity-relationship of saponins to enhance toxic effects of agrostin. Planta Med., 2005, 71(11), 1088-1090.
124. Ghosh, P.; Batra, J.K. The differential catalytic activity of ribosome-inactivating proteins saporin 5 and 6 is due to a single substitution at position 162. Biochem. J., 2006, 400(1), 99-104.
125. Zarovni, N.; Vago, R.; Solda, T.; Monaco, L.; Fabbrini, M.S. Saporin as a novel suicide gene in anticancer gene therapy. Cancer Gene Ther., 2007, 14, 165-173.
126. Weyergang, A.; Selbo, P.K.; Berg, K. Photochemically stimulated drug delivery increases the cytotoxicity and specificity of EGF-saporin. J. Control Rel., 2006, 111(1-2), 165-173.
127. Dietze, A.;, Selbo, P.K.; Prasmickaite, L.; Weyergang, A.; Bonsted, A.; Engesaeter, B.; Hogset, A.; Berg, K. Photochemical internalization (PCI): a new modality for light activation of endocytosed therapeuticals. J. Environ. Pathol. Toxicol. Oncol., 2006, 25(1-2), 521-536. Review.
128. Bachran, C.; Sutherland, M.; Heisler, I.; Hebestreit, P.; Melzig, M.F.; Fuchs, H. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure. Exp. Biol. Med. (Maywood), 2006, 231(4), 412-420.
129. Yip, W.L.; Weyergang, A.; Berg, K.; Tønnesen, H.H.; Selbo, P.K. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells. Mol. Pharm., 2007, 4(2), 241-251.
130. Flavell, D.J.; Warnes, S.L.; Bryson, C.J.; Field, S.A.; Noss, A.L.; Packham, G.; Flavell, S.U. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma. Br. J. Haematol., 2006, 134(2), 157-170.
131. Bolognesi, A.; Polito, L.; Farini, V.; Bortolotti, M.; Tazzari, P.L.; Ratta, M.; Ravaioli, A.; Horenstein, A.L.; Stirpe, F.; Battelli, M.G.; Malavasi, F. CD38 as a target of IB4 mA1 carrying saporin-S6: design of an immunotoxin for ex vivo depletion of hematological CD38+ neoplasia. J. Biol. Regul. Homeost. Agents, 2005, 19(3-4),145-152.
132. Bonini, F.; Traini, R.; Comper, F.; Fracasso, G.; Tomazzolli, R.; Dalla Serra, M.; Colombatti, M. N-terminal deletion affects catalytic activity of saporin toxin. J. Cell Biochem., 2006, 98(5), 1130-1139.
133. Geden, S.E.; Gardner, R.A.; Fabbrini, M.S.; Ohashi, M.; Phanstiel, IV O.; Teter, K. Lipopolyamine treatment increases the efficacy of intoxication with saporin and an anticancer saporin conjugate. FEBS J., 2007, 274(18), 4825-4836.
134. Daniels, T.R.; Ng, P.P.; Delgado, T.; Lynch, M.R.; Schiller, G.; Helguera, G.; Penichet, M.L. Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells. Mol. Cancer Ther., 2007, 6(11), 2995-3008.
135. Lai, P.S.; Pai, C.L.; Peng, C.L.; Shieh, M.J.; Berg, K.; Lou, P.J. Enhanced cytotoxicity of saporin by polyamidoamine dendrimer conjugation and photochemical internalization. J. Biomed. Mater. Res. A, 2008, 87(1), 147-155.
136. Hess, P.R.; Barnes, C.; Woolard, M.D.; Johnson, M.D.; Cullen, J.M.; Collins, E.J.; Frelinger, J.A. Selective deletion of antigenspecific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin. Blood, 2007, 109(8), 3300-3307.
137. Li, Z.; Qu, Y.; Li, H.; Yuan, J. Truncations of gelonin lead to a reduction in its cytotoxicity. Toxicology, 2007, 231(2-3), 129-136.
138. Mohamedali, K.A.; Poblenz, A.T.; Sikes, C.R.; Navone, N.M.; Thorpe, P.E.; Darnay, B.G.; Rosenblum, M.G. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel. Cancer Res., 2006, 66(22), 10919-10928.
139. Hsu, A.R.; Cai,W.; Veeravagu, A.; Mohamedali, K.A.; Chen, K.; Kim, S.; Vogel, H, Hou, L.C.;Tse, V.; Rosenblum, M.G.; Chen, X.. Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. J. Nucl. Med., 2007, 48(3), 445-454.
140. Nimmanapalli, R.; Lyu, M.A.; Du, M.; Keating, M.J.; Rosenblum, M.G.; Gandhi, V. The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R-positive CLL cells. Blood, 2007, 109(6), 2557-2564.
141. Lyu, M.A.; Cheung, L.H.; Hittelman, W.N.; Marks, J.W.; Aguiar, R.C.; Rosenblum M.G. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA. Mol. Cancer Ther., 2007, 6(2), 460-470.
142. Chu, T,C,; Marks, J.W.; 3rd, Lavery, L.A.; Faulkner, S.; Rosenblum, M.G.; Ellington, A.D.; Levy, M. Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res., 2006, 66(12), 5989-5992.
143. Li, J.; Xia, X.; Nie, H.; Smith, M.A.; Zhu, X. PKC inhibition is involved in trichosanthin-induced apoptosis in human chronic myeloid leukemia cell line K562. Biochim. Biophys. Acta, 2007, 1770(1), 63-70.
144. Iglesias, R.; Pérez, Y.; Citores, L.; Ferreras, J.M.; Méndez, E.; Girbés, T. Elicitor-dependent expression of the ribosome-inactivating protein beetin is developmentally regulated. J. Exp. Bot., 2008, 59(6), 1215-1223.
145. Monti, B., D'Alessandro, C.; Farini, V.; Bolognesi, A.; Polazzi, E.; Contestabile, A.; Stirpe, F.; Battelli, M.G. In vitro and in vivo toxicity of type 2 ribosome-inactivating proteins lanceolin and stenodactylin on glial and neuronal cells. Neurotoxicology, 2007, 28(3), 637-644.
146. Stirpe, F.; Bolognesi, A.; Bortolotti, M.; Farini, V; Lubelli, C.; Pelosi, E.; Polito, L.; Dozza, B.; Strocchi, P.; Chambery, A.; Parente, A.; Barbieri, L. Characterization of highly toxic type 2 ribosome-inactivating proteins from Adenia lanceolata and Adenia stenodactyla (Passifloraceae). Toxicon, 2007, 50(1), 94-105.
147. Chambery, A.; Severino, V.; Stirpe, F.; Parente, A. Cloning and expression of the B chain of volkensin, type 2 ribosome inactivating protein from Adenia volkensii harms: co-folding with the A chain for heterodimer reconstitution. Protein Expr. Purif., 2007, 51(2), 209-215.
148. Castilho, P.V.; Goto, L.S.; Roberts, L.M.; Araújo, A.P. Isolation and characterization of four type 2 ribosome inactivating pulchellin isoforms from Abrus pulchellus seeds. FEBS J., 2008, 275(5), 948-959.
149. Bagaria, A.; Surendranath, K.; Ramagopal, U.A.; Ramakumar, S.; Karande, A.A., Structure-function analysis and insights into the reduced toxicity of Abrus precatorius agglutinin I in relation to abrin. J. Biol. Chem., 2006, 281(45), 34465-34474.
150. Voss, C.; Eyol, E.; Frank, M.; von der Lieth, C.W.; Berger, M.R. Identification and characterization of riproximin, a new type II ribosome-inactivating protein with antineoplastic activity from Ximenia americana. FASEB J., 2006, 20(8), 1194-1196.
151. Begam, M.; Kumar, S.; Roy, S.; Campanella, J.J.; Kapoor, H.C. Molecular cloning and functional identification of a ribosome inactivating/ antiviral protein from leaves of post-flowering stage of Celosia cristata and its expression in E. coli. Phytochemistry, 2006, 67, 2441-2449.
152. Meyer, A.; Rypniewski, W.; Celewicz, L.; Erdmann, V.A.; Voelter, W.; Singh, T.P.; Genov, N.; Barciszewski, J.; Betzel, Ch. The mistletoe lectin I-phloretamide structure reveals a new function of plant lectins. Biochem. Biophys. Res. Commun., 2007, 364(2), 195-200.
153. Mishra, V.; Bilgrami, S.; Sharma, R.S.; Kaur, P.; Yadav, S.; Krauspenhaar, R.; Betzel, C.; Voelter, W.; Babu, C.R.; Singh, T.P. Crystal structure of himalayan mistletoe ribosome-inactivating protein reveals the presence of a natural inhibitor and a new functionally active sugar-binding site. J. Biol. Chem., 2005, 280(21), 20712-20721.
154. Lubelli, C.; Chatgilialoglu, A.; Bolognesi, A.; Strocchi, P.; Colombatti, M.; Stirpe, F. Detection of ricin and other ribosome-inactivating proteins by an immuno-polymerase chain reaction assay. Anal. Biochem., 2006, 355(1), 102-109.
155. Wang, T.; Zou, Y.S.; Zhu, D.W.; Azzi, A.; Liu, W.Y.; Lin, S.X. Cinnamomin: separation, crystallization and preliminary X-ray diffraction study. Amino Acids, 2008, 34(2), 239-243.
156. Savino, C.; Federici, L.; Ippoliti, R.; Lendaro, E.; Tsernoglou, D. Theorystal structure of saporin S06 from Saponarica officinalis and its interaction with the ribosome FEBS Lett., 2000, 470, 239-243.
157. Ren, J.; Wang, Y.; Dong, Y.; Stuart, D.I. The N-glycosidase mechanism of ribosome-inactivating proteins implied by crystal structures of alpha-momorcharin. Structure, 1994, 2(1), 7-16.
158. Husain, J.; Tickle, I.J.; Wood, S.P. Crystal structure of momordin, a type I ribosome inactivating protein from the seeds of Momordica charantia. FEBS Lett., 1994, 342(2), 154-158.
159. Kaku, H.; Kaneko, H.; Minamihara, N.; Iwata, K.; Jordan, E.T.; Rojo, M.A.; Minami-Ishii, N.; Minami, E.; Hisajima, S.; Shibuya, N. Elderberry bark lectins evolved to recognize Neu5Ac alpha2,6Gal/ GalNAc sequence from a Gal/GalNAc binding lectin through the substitution of amino-acid residues critical for the binding to sialic acid. J. Biochem., 2007, 142(3), 393-401.
160. Benitez, J.; Ferreras, J.M.; Munoz, R.; Arias, Y.; Iglesias, R.; Cordoba-Diaz, M.; deVillar, R.; Girbes, T. Cytotoxicity of an ebulin 1-anti-human CD105 immunotoxin on mouse of fibroblast (L929) and rat myoblasts (L6E9) cells expressing human CD105. Med. Chem., 2005, 1, 65-70.
161. Muñoz, R.; Arias, Y.; Ferreras, J.M.; Rojo, M.A.; Gayoso, M.J.; Nocito, M.; Benitez, J.; Jiménez, P.; Bernabéu, C.; Girbés, T. Targeting a marker of the tumour neovasculature using a novel antihuman CD105-immunotoxin containing the non-toxic type 2 ribosome-inactivating protein nigrin b. Cancer Lett., 2007, 256(1), 73-80.
162. Wang, B.Z.; Zou, W.G.; Liu, W.Y.; Liu, X.Y. The lower cytotoxicity of cinnamomin (a type II RIP) is due to its B-chain. Arch. Biochem. Biophys., 2006, 451(1), 91-96.
163. Lavastre, V.; Binet, F.; Moisan, E.; Chiasson, S.; Girard, D. Viscum album agglutinin-I induces degradation of cytoskeletal proteins in leukaemia PLB-985 cells differentiated toward neutrophils: cleavage of non-muscle myosin heavy chain-IIA by caspases. Br. J. Haematol., 2007, 138(4), 545-554.
164. Semiglazov, V.F.; Stepula, V.V.; Dudov, A.; Schnitker, J.; Mengs, U. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial. Anticancer Res., 2006, 26(2B), 1519-1529.
165. Freudlsperger, C.; Thies, A.; Pfüller, U.; Schumacher, U. The proteasome inhibitor bortezomib augments anti-proliferative effects of mistletoe lectin-I and the PPAR-gamma agonist rosiglitazone in human melanoma cells. Anticancer Res., 2007, 27(1A), 207-213.
166. Thies, A.; Dautel, P.; Meyer, A.; Pfüller, U.; Schumacher, U. Low-dose mistletoe lectin-I reduces melanoma growth and spread in a scid mouse xenograft model. Br. J. Cancer, 2008, 98(1), 106-112.
167. Khil, L.Y.; Kim, W.; Lyu, S.; Park, W.B.; Yoon, J.W.; Jun, H.S. Mechanisms involved in Korean mistletoe lectin-induced apoptosis of cancer cells. World J. Gastroenterol., 2007, 13(20), 2811-2818.
168. Kelter, G.; Schierholz, J.M.; Fischer, I.U.; Fiebig, H.H. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro. Anticancer Res., 2007, 27(1A), 223-233.
169. Pryme, I.F.; Bardocz, S.; Pusztai, A.; Ewen, S.W. Suppression of growth of tumour cell lines in vitro and tumours in vivo by mistletoe lectins. Histol. Histopathol., 2006, 21(3), 285-299. Review.
170. Surendranath, K.; Karande, A.A. A neutralizing antibody to the a chain of abrin inhibits abrin toxicity both in vitro and in vivo. Clin. Vaccine Immunol., 2008, 15(5), 737-743.
171. Huber, R.; Rostock, M.; Goedl, R.; Lüdtke, R.; Urech, K.; Klein, R. Immunologic effects of mistletoe lectins: a placebo-controlled study in healthy subjects. J. Soc. Integr. Oncol., 2006, 4, 3-7.
172. Kang, T.B.; Yoo, Y.C.; Lee, K.H.; Yoon, H.S.; Her, E.; Kim, J.B.; Song, S.K. Korean mistletoe lectin (KML-IIU) and its subchains induce nitric oxide (NO) production in murine macrophage cells. J. Biomed. Sci., 2008, 15(2), 197-204.
173. Mantis, N.J.; McGuinness, C.R.; Sonuyi, O.; Edwards, G.; Farrant, S.A. Immunoglobulin A antibodies against ricin A and B subunits protect epithelial cells from ricin intoxication. Infect. Immun., 2006, 74(6), 3455-3462.
174. Zhou, X.; Li, X.D.; Yuan, J.Z.; Tang, Z.H.; Liu, W.Y. Toxicity of cinnamomin-a new type II ribosome-inactivating protein to boll-worm and mosquito. Insect Biochem. Mol. Bio., 2000, 30, 259-264.
175. Shahidi Noghabi, S.; Van Damme, E.; Smagghe, G. Bioassays for insecticidal activity of iris ribosome-inactivating proteins expressed in tobacco. Commun. Agric. Appl. Biol. Sci., 2006, 71(1), 285-289.
176. Keener, W.K.; Rivera, V.R.,Young, C.C.; Poli, M.A. An activity-dependent assay for ricin and related RNA N-glycosidases based on electrochemiluminescence. Anal. Biochem., 2006, 357(2), 200-207.
177. Ostin, A.; Bergstrom, T.; Fredriksson, S.A.; Nilsson, C. Solvent-assisted trypsin digestion of ricin for forensic identification by LCESI MS/MS. Anal. Chem., 2007, 79, 6271-6278.
178. Hussein, F.; Daniels, R. Improvement of an enzyme linked lectin assay to determine recombinant mistletoe lectin I. J. Pharm. Biomed. Anal., 2007, 43(2), 758-762.
179. Lubelli, C.; Chatgilialoglu, A.; Bolognesi, A.; Strocchi, P.; Colombatti, M.; Stirpe, F. Detection of ricin and other ribosome-inactivating proteins by an immuno-polymerase chain reaction assay. Anal. Biochem., 2006, 355(1), 102-109.
180. Mak AN, Wong YT, An YJ, Cha SS, Sze KH, Au SW, Wong KB, Shaw PC. Structural-function study of maize ribosome-inactivating protein: implications for the internal inactivation region and the sole glutamate in the active site. Nucleic Acids Res., 2007, 35(18), 6259-6267.
181. Reinbothe, S.; Reinbothe, C.; Lehmann, J.; Becker, W.; Apel, K.; Partier, B. Proc. Natl. Acad. Sci. USA, 1999, 91, 7012-7016.
182. Dowd, P.F.; Holmes, R.A.; Pinkerton, T.S.; Johnson, E.T.; Lagrimini, L.M.; Boston, R.S. Relative activity of a tobacco hybrid expressing high levels of a tobacco anionic peroxidase and maize ribosome-inactivating protein against Helicoverpa zea and Lasioderma serricorne. J. Agric. Food Chem., 2006, 54(7), 2629-2634.
183. Wang, H.X.; Jacob, J.; Wingfield, P.T.; Palmer, I.; Stahl, S.J.; Kaufman, J.D.; Huang, P.L.; Lee-Huang, S.; Torchia, D.A. Anti-HIV and anti-tumor protein MAP30, a 30 kDa single-strand type-I RIP, shares similar secondary structure and beta-sheet topology with the A chain of ricin, a type-II RIP. Protein Sci., 2000, 9, 138-144.
184. Liu, R.S.; Yang, J.H.; Liu, W.Y. Isolation and enzymatic characterization of lamjapin, the first ribosome-inactivating protein from cryptogamic algal plant (Laminaria japonica A). Eur. J. Biochem., 2002, 269, 4746-4752.
185. Shu, S.H.; Xie, G.Z.; Guo, X.L.; Wang, M. Purification and characterization of a novel ribosome-inactivating protein from seeds of Trichosanthes kirilowii Maxim. Protein Expr. Purif., 2009, 67(2): 120-125.
186. Huang, P.L.; Sun, Y.; Chen, H.C.; Kung, H.F.; Lee-Huang, S. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active. Biochem. Biophys. Res. Commun., 1999, 262(3), 615-623.
187. Wang, Y.X.; Neamati, N.; Jacob, J.; Stajl, S.J.; Kaufman, J.D.; Huang, P.L.; Huang, P.L.; Windslow, H.E.; Windslow, H.E.; Pomier, Y.; Wing field, P.T.; Lee-Huang, S.; Bax, A.; Torchia, D.A.; Solution structure of anti-HIV-1 and anti-tumor protein MAP30: structural insights into its multiple functions. Cell, 1999, 99, 433-442
188. Hossann, M.; Li, Z.; Shi, Y.; Kreilinger, U.; Büttner, J.; Vogel, P.D.; Yuan, J.; Wise, J.G.; Trommer, W.E. Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of myasthenia gravis. Protein Expr. Purif., 2006, 46(1), 73-84.
189. Zhao, W.L.; Zhang, F.; Feng, D.; Wu, J.; Chen, S.; Sui, S.F. A novel sorting strategy of trichosanthin for hijacking human immunodeficiency virus type 1. Biochem. Biophys. Res. Commun., 2009, 384(3), 347-351.
190. He, W.J.; Liu, W.Y. Cinnamomin: a multifunctional type II ribosome-inactivating protein. Int. J. Biochem. Cell Biol., 2003, 35, 1021-1027.